Purpose: Deep-vein thrombosis (DVT) and pulmonary embolism (PE) are associated with major morbidity and mortality, with their burden often extending to longer-term complications such as event ...
Please provide your email address to receive an email when new articles are posted on . Dexamethasone was associated with decreased risks for thrombotic disorders after total joint arthroplasty.
Temple Health is on a mission to raise awareness about one of the least-known and most under-diagnosed serious medical conditions – a potentially deadly one that can be prevented, if caught early.
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Pulmonary embolism admission rates in 2023 have not ...
Functional impairment (FI) after hematopoietic cell transplantation (HCT) and impact on quality of life (QOL). Bupropion for hot flashes control in breast cancer survivors: A prospective, double-blind ...
After experiencing a steady drop throughout the first decade of this century, the death rate from pulmonary embolism—in which a blood clot travels to the lungs and blocks blood flow—is back on the ...
New guidelines from the American Heart Association and ACC warn that pulmonary embolism, a sudden lung artery blockage, can ...
In an editorial, one expert said the choice of DOAC in VTE is “no longer a toss-up,” with apixaban the clear winner.
Venous thromboembolism includes deep vein thrombosis (DVT) and pulmonary embolism, which have incidence rates of between 1 and 2 cases per 1000 people for the first episode.1,2 Strong, provoking risk ...
Thrombosis and embolism are both blood clots that reduce or block blood flow inside your blood vessels. They’re two different yet serious conditions. Here’s a look at the differences and similarities.
If you are diagnosed with deep vein thrombosis (DVT), one treatment option your doctor may recommend is thrombolytic therapy. These are drugs that break up or dissolve blood clots. They can be an ...
A retrospective, observational, parallel, comparative cohort study was conducted using the PharMetrics Patient-Centric Database, which is comprised of fully adjudicated medical and pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results